ALBAlbemarle Corporation

Materials · Plastics & Resins · NYSE

Albemarle Corporation was incorporated in Virginia in 1993. 10-K, Item 1

Employees: 7,800
Headquarters: Charlotte, NC
CEO: J. Kent Masters
Next results: around Feb 10, 2027

The numbers ALB said it expected, in its earnings releases of the last 3 years, next to what it then reported for the same period. Each target links to the sentence in the release; each result to the 10-Q or 10-K it was first reported in.

Of 2 range targets with a reported result: 0 came in above the last range given, 0 within it, 2 below it.

Target	What the company said	Reported	Result
EBITDA (company-defined) Fiscal 2026	Given $275.00M to $325.00M release 2026-08-05 Raised $350.00M to $375.00M release 2026-11-04	–	No standard number
The company's words Improving full-year 2026 outlook considerations including: … Increasing full-year Specialties net sales outlook to $1.4 to $1.6 billion and adjusted EBITDA outlook to $275 to $325 million, due to stronger-than-expected pricing and volume performance year to date. release 2026-08-05 Improving full-year 2026 outlook considerations including: … Specialties adjusted EBITDA of $350-$375 million (up from $275-$325 million), in part driven by ongoing cost and productivity improvements. release 2026-11-04
Capital expenditures Fiscal 2026	Given $500.00M release 2026-08-05 Lowered $300.00M to $350.00M release 2026-11-04	–	Not reported yet
The company's words Albemarle expects its full-year 2026 capital expenditures to be approximately $500 million, down 15% compared to 2025 due to ongoing capital efficiency improvements. release 2026-08-05 Albemarle now expects its full-year 2026 capital expenditures to b e $300-$350 million, reflecting continued benefits from our focused capital efficiency improvements as well as resequencing of some earl y-stage project spend. release 2026-11-04
Revenue Fiscal 2026	Given $1.40B to $1.60B release 2026-08-05	–	Not reported yet
The company's words Improving full-year 2026 outlook considerations including: … Increasing full-year Specialties net sales outlook to $1.4 to $1.6 billion and adjusted EBITDA outlook to $275 to $325 million, due to stronger-than-expected pricing and volume performance year to date. release 2026-08-05
EBITDA (company-defined) Fiscal 2025 (ended 2025-12-31)	Given $600.00M to $700.00M release 2025-11-05	–	No standard number
The company's words Energy Storage FY 2025E Observed market H1 2025 average H1 2024 range Q4 2023 average price case(a) Average lithium … Adjusted EBITDA $0.6 - $0.7 billion release 2025-11-05
Free cash flow (company-defined) Fiscal 2025 (ended 2025-12-31)	Given $300.00M to $400.00M release 2025-11-05	–	No standard number
The company's words Expect to achieve positive free cash flow (a) of $300 to $400 million for the full year 2025. release 2025-11-05
Capital expenditures Fiscal 2025 (ended 2025-12-31)	Given $800.00M to $900.00M release 2024-11-06 Lowered $700.00M to $800.00M release 2025-02-12 Kept $700.00M to $800.00M release 2025-04-30 Lowered $650.00M to $700.00M release 2025-07-30 Lowered $600.00M release 2025-11-05	$589.80M 10-K filed 2026-02-11	Below the range
The company's words Decreasing FY 2025 capital expenditures by approximately 50% versus FY 2024 to an anticipated range of $800 million to $900 million release 2024-11-06 Further reducing expected full-year 2025 capital expenditures by $100 million; now targeting capital expenditures in the range of $700 and $800 million, or down more than 50% year-over-year release 2025-02-12 Albemarle expects its 2025 capital expenditures to be in the range of $700 million to $800 million, down more than 50% from $1.7 billion in 2024. release 2025-04-30 Albemarle expects its 2025 capital expenditures to be between $650 and $700 million, down approximately 60% from $1.7 billion in 2024. release 2025-07-30 Reducing full-year 2025 capital expenditures outlook to approximately $600 million. release 2025-11-05
Capital expenditures Fiscal 2024 (ended 2024-12-31)	Given $1.60B to $1.80B release 2024-02-14 Raised $1.70B to $1.80B release 2024-07-31	$1.69B 10-K filed 2025-02-12	Below the range
The company's words Albemarle expects its 2024 capital expenditures to be in the range of $1.6 billion to $1.8 billion, down from approximately $2.1 billion in 2023. release 2024-02-14 2024 Other Corporate Outlook Considerations … Capital expenditures are now expected to be at the high-end of $1.7 to $1.8 billion related to timing of capital spending. release 2024-07-31

1 target far from the company's reported total, so not compared (usually a target for one product, segment or definition)

Revenue, Fiscal 2025 (ended 2025-12-31): said $2.50B to $2.60B, reported $5.14B. The company's words

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (13 releases since 2023-11-01), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Work on ALB in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/ALB/export.csv") into a cell.